Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome-Reference-Cited by-同舟云学术

Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome

Published:2022-11-09 Issue:1 Volume:41 Page:159-166
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Ren Yanling¹²³^ORCID,Lang Wei¹²³,Mei Chen¹²³^ORCID,Luo Yingwan¹²³,Ye Li¹²³,Wang Lu¹²³,Zhou Xinping¹²³^ORCID,Xu Gaixiang¹²³,Ma Liya¹²³,Jin Jie¹²³,Tong Hongyan¹²³

Affiliation:

1. Myelodysplastic Syndromes Diagnosis and Therapy Center Department of Hematology The First Affiliated Hospital College of Medicine Zhejiang University Hangzhou Zhejiang China

2. Department of Hematology The First Affiliated Hospital College of Medicine Zhejiang University Hangzhou Zhejiang China

3. Zhejiang Provincial Clinical Research Center for Hematologic Diseases Hangzhou Zhejiang China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3099

Reference30 articles.

1. Advances in myelodysplastic syndrome

2. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

3. Clinical Effect of Point Mutations in Myelodysplastic Syndromes

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA Profiles in Patients with Hematological Malignancy at Different Stages of the Disease: A Preliminary Study;Biomedicines;2024-08-22

2. RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives;Blood Cancer Journal;2024-04-24

3. Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China;Cancer Medicine;2023-02-17